Inaugural Polypoidal Choroidal Vasculopathy Research Network Meeting, 4 Oct 2018, Singapore
4 October 2018
In conjunction with the National Healthcare Group (NHG) Eye Institute 8th International Ophthalmology Congress (IOC) 2018, Polypoidal Choroidal Vasculopathy Research Network (PCVNet) held their inaugural meeting at Faber Peak, Singapore, on 4 October 2018. The meeting was funded by Novartis and Heidelberg Engineering. PCVNet is an international research network formed to encourage more investigator-initiated multi-centre studies for Polypoidal Choroidal Vasculopathy (PCV) and related ocular conditions. It aims to reduce visual morbidity due to PCV and to deepen understanding of the disease. The research network seeks be a platform for the exchanging of ideas and intellectual discourse regarding topics on PCV patient care. Details of the PCVNet constitution, current knowledge gaps in PCV research, and potential studies were presented and widely discussed during the meeting. The event concluded with SCRI’s Epidemiology, Business Operations, Project Management and Research Monitoring staff partaking in a dinner held at the end of the day.
PCVNet Inaugural Meeting @ Faber Peak, Singapore
Set off to Faber Peak
Team enjoying the view @ Faber Peak
Prof Lim Tock Han opening the meeting
A/Prof Teoh Yee Leong introducing SCRI to the team
Team in active discussion of the potential studies
It is dinner time
Next PCVNet meeting will be hosted by Dr Sjakon Tahijia in Bali
- How to reach us
Currently, we are still a closed group and membership is via invitations/ recommendations only. However, if you are interested to know more about PCVNet, you are most welcome to contact the Network Secretariat for more information at email@example.com.